132 related articles for article (PubMed ID: 36422295)
1. Molecular Dynamics Study on Selected Bioactive Phytochemicals as Potential Inhibitors of HIV-1 Subtype C Protease.
Shode FO; Uhomoibhi JO; Idowu KA; Sabiu S; Govender KK
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422295
[TBL] [Abstract][Full Text] [Related]
2. Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.
Gupta A; Jamal S; Goyal S; Jain R; Wahi D; Grover A
BMC Bioinformatics; 2015; 16 Suppl 19(Suppl 19):S10. PubMed ID: 26695135
[TBL] [Abstract][Full Text] [Related]
3. Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2:
Kumar N; Singh A; Gulati HK; Bhagat K; Kaur K; Kaur J; Dudhal S; Duggal A; Gulati P; Singh H; Singh JV; Bedi PMS
Phytomed Plus; 2021 Nov; 1(4):100083. PubMed ID: 35403086
[TBL] [Abstract][Full Text] [Related]
4. Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.
Chetty S; Bhakat S; Martin AJ; Soliman ME
J Biomol Struct Dyn; 2016; 34(1):135-51. PubMed ID: 25671669
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches.
Khan A; Khan SU; Khan A; Shal B; Rehman SU; Rehman SU; Htar TT; Khan S; Anwar S; Alafnan A; Rengasamy KR
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807562
[TBL] [Abstract][Full Text] [Related]
6. An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV-1 protease variants.
Nayak C; Chandra I; Singh SK
J Cell Biochem; 2019 Jun; 120(6):9063-9081. PubMed ID: 30506751
[TBL] [Abstract][Full Text] [Related]
7. Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs.
Moonsamy S; Bhakat S; Ramesh M; Soliman ME
Cell Biochem Biophys; 2017 Mar; 75(1):49-64. PubMed ID: 27981421
[TBL] [Abstract][Full Text] [Related]
8. Interaction of I50V mutant and I50L/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir): molecular dynamics simulation and binding free energy studies.
Meher BR; Wang Y
J Phys Chem B; 2012 Feb; 116(6):1884-900. PubMed ID: 22239286
[TBL] [Abstract][Full Text] [Related]
9. Interaction of compounds derived from the Chinese medicinal formula Huangqi Guizhi Wuwu Tang with stroke-related numbness and weakness targets: An in-silico docking and molecular dynamics study.
Lee S; Wong AR; Yang AWH; Hung A
Comput Biol Med; 2022 Jul; 146():105568. PubMed ID: 35508083
[TBL] [Abstract][Full Text] [Related]
10. Structure-based virtual screening and molecular dynamics studies to explore potential natural inhibitors against 3C protease of foot-and-mouth disease virus.
Sahoo S; Lee HK; Shin D
Front Vet Sci; 2023; 10():1340126. PubMed ID: 38298458
[TBL] [Abstract][Full Text] [Related]
11. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study.
Maphumulo SI; Halder AK; Govender T; Maseko S; Maguire GEM; Honarparvar B; Kruger HG
Chem Biol Drug Des; 2018 Nov; 92(5):1899-1913. PubMed ID: 30003668
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques.
Okafor SN; Angsantikul P; Ahmed H
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293006
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
[No Abstract] [Full Text] [Related]
15. The pharmacokinetic properties of HIV-1 protease inhibitors: A computational perspective on herbal phytochemicals.
Kehinde I; Ramharack P; Nlooto M; Gordon M
Heliyon; 2019 Oct; 5(10):e02565. PubMed ID: 31720444
[TBL] [Abstract][Full Text] [Related]
16. Exploring the potency of currently used drugs against HIV-1 protease of subtype D variant by using multiscale simulations.
Sk MF; Roy R; Kar P
J Biomol Struct Dyn; 2021 Feb; 39(3):988-1003. PubMed ID: 32000612
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway.
Taura M; Kariya R; Kudo E; Goto H; Iwawaki T; Amano M; Suico MA; Kai H; Mitsuya H; Okada S
Free Radic Biol Med; 2013 Dec; 65():778-788. PubMed ID: 23973637
[TBL] [Abstract][Full Text] [Related]
18. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
19. Docking Study on Anti-HIV-1 Activity of Secondary Metabolites from Zingiberaceae Plants.
Zubair MS; Maulana S; Widodo A; Mukaddas A; Pitopang R
J Pharm Bioallied Sci; 2020 Nov; 12(Suppl 2):S763-S767. PubMed ID: 33828375
[TBL] [Abstract][Full Text] [Related]
20. Investigating Fungi-Derived Bioactive Molecules as Inhibitor of the SARS Coronavirus Papain Like Protease: Computational Based Study.
Belachew AM; Feyisa A; Mohamed SB; W/Mariam JF
Front Med (Lausanne); 2021; 8():752095. PubMed ID: 34746186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
